AACR 2009: Selecting appropriate first line lung cancer therapy
Dr Paul Bunn - University of Colorado, Denver, USA erlotininb, cetuximab or gefitinib for lung cancer in pill form- less toxic and better tolerated, better survival for patients with EGFR gene mutation.
